Mural Oncology Investigational Site

Atlanta, Georgia 30322

0 studies enrolling now · 2 studies all time

What they study most

Advanced Solid Tumors, Squamous Cell Carcinoma of Head and Neck

Studies at this site

• A Study of ALKS 4230 (Nemvaleukin Alfa) With Pembrolizumab in Head and Neck Cancer — Completed
• A Dose Escalation and Cohort Expansion Study of Subcutaneously-Administered Cytokine ALKS 4230 (Nemvaleukin Alfa) as a Single Agent and in Combination With Anti-PD-1 Antibody (Pembrolizumab) in Subjects With Select Advanced or Metastatic Solid Tumors (ARTISTRY-2) — Completed